| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Schoenberg Mark is a Chief Medical Officer at UroGen Pharma Ltd.. Recent SEC Form 4 filings include 0 buys and 14 sells.
Estimated insider holdings value: $4.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2025 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sell | 10,000 | $25.00 | $250,000.00 | -6.7% | -18.5% | - | |
| Sep 8, 2025 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sale+OE | 871 | $19.11 | $16,644.81 | -0.6% | +7.7% | - | |
| Aug 11, 2025 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sell | 10,000 | $17.69 | $176,900.00 | -6.3% | +26.8% | - | |
| Jul 28, 2025 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sale+OE | 5,149 | $19.14 | $98,551.86 | -3.2% | +10.3% | - | |
| Jun 9, 2025 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sale+OE | 5,162 | $7.37 | $38,043.94 | -3.3% | +205.1% | - | |
| Jan 31, 2025 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sale+OE | 4,551 | $11.14 | $50,698.14 | -1.0% | +3.6% | +78.1% | |
| Sep 9, 2024 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sale+OE | 859 | $13.08 | $11,235.72 | -0.6% | -8.8% | +55.0% | |
| Jun 10, 2024 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sale+OE | 5,153 | $13.08 | $67,401.24 | -3.4% | +4.5% | -44.8% | |
| Mar 18, 2024 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sell | 12,000 | $14.05 | $168,600.00 | -7.9% | +26.1% | -20.5% | |
| Jan 31, 2024 | URGN Urogen Pharma Ltd. | Chief Medical Officer | Sale+OE | 3,789 | $15.74 | $59,638.86 | -0.8% | -12.0% | -27.7% |